New & Noteworthy

Jul 19, 2017
Pharmaceutical Executive
Dogs and kids both spontaneously develop a number of cancers, making it a no-brainer for those on both sides of the disease to work together in finding new therapies.
Jul 17, 2017
By Pharmaceutical Executive Editors
The health promises of big data will not be met unless the right technology is put in place to ensure that data can flow freely and fast across a WAN, writes David Trossell.
Jul 17, 2017
Pieter De Richter explores how the molecular diagnostics landscape—and the very way we think about fighting cancer—is set to change dramatically in the coming decades.
Jul 13, 2017
Pharmaceutical Executive
Digital interventions in drug adherence regimes are evolving to new levels of sophistication, but patient-behavior and privacy issues still present significant challenges.
Jul 12, 2017
Pharmaceutical Executive
The industry’s potential in tapping digital health to transform patient care hinges on new shifts in culture and business strategy. Michelle Maskaly reports.
Jul 10, 2017
Separating the meaningful from the merely novel, Bill Drummy outlines his Top Ten digital marketing trends for 2017.
Jul 07, 2017
Pharmaceutical Executive
David Keane outlines four best practices in implementing AI-based technology to help achieve physician-engagement wins.
Jul 07, 2017
Pharmaceutical Executive
For better alignment of coverage and risk, evidence-based arguments are critical during the underwriting process, writes Daniel Brettler.
Jul 06, 2017
Big data has proven to be a valuable business asset, but using it to gain competitive advantage requires the right combination of strategy, technology and execution.
Jun 28, 2017
Pharmaceutical Executive
Pharm Exec's 17th annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.
native1_300x100
lorem ipsum